MACOM Technology Solutions vs Varex Imaging
MTSI and VREX side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MTSI and VREX compare
MACOM Technology Solutions is the larger company, worth 23 times as much as Varex Imaging ($17.7B against $762M).
On earnings, Varex Imaging is cheaper: it trades at 34.8× trailing earnings, against 53.8× for MACOM Technology Solutions.
MACOM Technology Solutions grew revenue faster over the last twelve months (37.3% versus 5.3% for Varex Imaging).
MACOM Technology Solutions keeps more of each dollar of sales as profit, with a net margin of 25.3% compared with 2.6% at Varex Imaging.
MACOM Technology Solutions scores higher on the StockData Score (17 against 7 for Varex Imaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MTSI | VREX |
|---|---|---|
| Size and price | ||
| Market cap | $17.7B | $762M |
| Share price | $232.06 | $18.10 |
| Change, 1 year | 35.8% | 46.6% |
| Change, 5 years | 199% | −38.7% |
| Beta (5Y) | 1.50 | 1.13 |
| Employees | 2,000 | 400 |
| StockData Score | ||
| Total score | 17 (better) | 7 |
| Valuation score | 2 | 3 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 6 (better) | 1 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 53.8× | 34.8× (better) |
| P/S | 13.3× | 0.9× (better) |
| P/B | 10.4× | 1.5× (better) |
| EV/EBITDA | 46.9× | 14.2× (better) |
| P/FCF | 60.6× | – |
| PEG | 1.08 | – |
| FCF yield | 1.7% (better) | −2.7% |
| Fair value | $167.09 | $19.43 |
| Margin of safety | −38.9% | 6.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 37.3% (better) | 5.3% |
| Revenue growth, 5Y average | 16.9% (better) | 2.7% |
| EPS growth, 5Y average | 51.5% | – |
| Profitability | ||
| Gross margin | 58.0% (better) | 34.3% |
| Operating margin | 23.0% (better) | 8.3% |
| Net margin | 25.3% (better) | 2.6% |
| FCF margin | 22.0% (better) | −2.3% |
| Return on equity | 22.2% (better) | 4.6% |
| Return on invested capital | 23.0% (better) | 8.3% |
| Financial health | ||
| Debt / equity | 0.20 (better) | 0.70 |
| Net debt / EBITDA | −1.23 | 3.43 (better) |
| Interest coverage | – | 1.9× |
| Current ratio | 2.53 | 3.38 (better) |
| Altman Z-score | 18.46 (better) | 2.27 |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 95.9% | 96.2% |
| Held by insiders | 6.8% | 2.0% |
| Insider net buying, 12 months | −$283M | −$2.6M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.0% | 4.9% |
Go deeper
- MTSI stock overview
- MTSI income statement
- MTSI valuation and score
- VREX stock overview
- VREX income statement
- VREX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.